G9828 HCPCS Level II code: Her2-targeted therapies administered during the initial course of treatment
CMS terminated G9828: its last date of service was Dec 31, 2020. It stays here for looking up older claims; newer services need a current code.
Official description
G9828Her2-targeted therapies administered during the initial course of treatment
Short description: Her-2 targ ther dur init tx
HCPCS · United States
Medicare details
The indicators CMS publishes with G9828 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Medical care
- BETOS category
- Undefined codes
- Added
- Jan 1, 2017
- Terminated after
- Dec 31, 2020
Where G9828 sits
- 1G codesProcedures and professional services
- 2Terminated G9828Her2-targeted therapies administered during the initial course of treatment
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code G9828 still valid?
No. CMS terminated G9828; its last date of service was Dec 31, 2020. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover G9828?
CMS lists G9828’s Medicare coverage as “Carrier judgment” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside G9828
All G codesG9822Patients who had an endometrial ablation procedure during the 12 months prior to the index date (exclusive of the index date)G9823Endometrial sampling or hysteroscopy with biopsy and results documented during the 12 months prior to the index date (exclusive of the index date) of the endometrial ablationG9824Endometrial sampling or hysteroscopy with biopsy and results not documented during the 12 months prior to the index date (exclusive of the index date) of the endometrial ablationG9825Her-2/neu negative or undocumented/unknownG9826Patient transferred to practice after initiation of chemotherapyG9827Her2-targeted therapies not administered during the initial course of treatmentG9829Breast adjuvant chemotherapy administeredG9830Her-2/neu positiveG9831Ajcc stage at breast cancer diagnosis = ii or iiiG9832Ajcc stage at breast cancer diagnosis = i (ia or ib) and t-stage at breast cancer diagnosis = t1cG9833Patient transfer to practice after initiation of chemotherapyG9834Patient has metastatic disease at diagnosis